Absorption |
Blood-Brain Barrier | BBB- | 0.9659 |
Human Intestinal Absorption | HIA+ | 0.9545 |
Caco-2 Permeability | Caco2+ | 0.8867 |
P-glycoprotein Substrate | Substrate | 0.7862 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8782 |
Non-inhibitor | 0.8383 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7489 |
Distribution |
Subcellular localization | Lysosome | 0.7248 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8468 |
CYP450 2D6 Substrate | Non-substrate | 0.9116 |
CYP450 3A4 Substrate | Non-substrate | 0.6386 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9070 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9268 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7726 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8402 |
Non-inhibitor | 0.8660 |
AMES Toxicity | AMES toxic | 0.7844 |
Carcinogens | Non-carcinogens | 0.9033 |
Fish Toxicity | High FHMT | 0.9975 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9407 |
Honey Bee Toxicity | Low HBT | 0.8853 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.7916 |
Carcinogenicity (Three-class) | Non-required | 0.6211 |